Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
Big Sorrento Valley cash to be had from Zika
San Diego biotech unit gets emergency FDA permission to test virus diagnostic kits
Zika carrier Aedes aegypti during blood meal
The number of San Diego Zika virus infections continues its relentless growth, bringing the county to within one case of California Zika count leader Los Angeles, but at least one local big-money biotech outfit is looking to prosper from the worldwide breakout.
As of July 29, according to the latest report from the California Department of Public Health, San Diego has registered 23 infections, including one non-resident; L.A. has posted 24 cases.
Two weeks earlier, on July 15, Los Angeles was California's number-one Zika county by a wider margin, with 22 cases, while San Diego reported a total of 16. All of the 114 cases reported statewide so far in 2015 and 2016, including San Diego's, are travel-associated, according to state health officials.
San Diego's first Zika case was determined to be sexually transmitted this past February. "A San Diego man was visiting Colombia where he sustained some mosquito bites in January," according to a March 25 advisory from the county health department.
"Four days before his return to the county in early February, he had the onset of subjective fever, arthralgia, and maculopapular rash. Upon arrival in San Diego, he was still symptomatic with rash and arthralgia and he had unprotected sexual contact with a non-pregnant woman who had no travel outside the county."
The notice continued, "Seven days after initial sexual contact with the man, the woman developed fever to 101° F and a blanching, salmon to red colored, maculopapular rash on her trunk. The rash spread to her neck and extremities over the next two days and she developed arthralgia in her hands and feet."
The woman was subsequently determined to be infected with Zika, according to the federal Centers for Disease Control, and mosquito transmission was ruled out.
"Neither patient reported mosquito bites in San Diego and no Aedes species mosquitoes were detected in traps set by the San Diego County Vector Control Program around the residences of either patient," said the report.
Meanwhile, the onetime San Diego biotech start-up formerly known as Gen-Probe is looking to make hay with an experimental clinical test for the virus, which causes birth defects in babies of infected mothers.
Bought by Hologic, Inc. for $3.8 billion in cash back in 2012, the unit, still based in San Diego's Sorrento Valley on Genetic Center Drive, was issued an emergency-use authorization last month for its "Aptima® Zika Virus assay for the qualitative detection of RNA from Zika virus in human serum and plasma specimens," according to a June 17 letter to the firm from federal Food and Drug Administration commissioner of food and drugs Robert M. Califf.
"There is no adequate, approved, and available alternative to the emergency use of the Aptima® Zika Virus assay for detecting Zika virus and diagnosing Zika virus infection," according to the letter, which adds, "Hologic, Inc. will report to FDA any suspected occurrence of false positive and false negative results and significant deviations from the established performance characteristics of the test of which Hologic, Inc. becomes aware."
Adds the document, The known and potential benefits of the Aptima® Zika Virus assay for detecting Zika virus and diagnosing Zika virus infection outweigh the known and potential risks of such product.”
Four South Florida Zika cases found last week to be due to mosquito bites have ratcheted up the political pressure in Washington to provide more federal cash to combat the virus, ultimately translating to a potential windfall for Hologic.
But the news in San Diego is not all good for the company. In February of this year, Karmen Smiley, a former Genprobe accountant, sued Hologic in California superior court here, alleging she was harassed and let go after calling attention to illegal accounting practices by the firm last year, according to MassDevice.
“During her entire time working for Gen-Probe, and for the first few years working for Hologic, Ms. Smiley was never disciplined. In fact, she received numerous performance awards during her tenure. As recently as 2014, Ms. Smiley received a performance review stating she consistently meets and occasionally exceeds expectations,” the complaint said.
Hologic has denied the allegations, and the case has been moved to federal court, where it remains under litigation.
Here's something you might be interested in.
Big Sorrento Valley cash to be had from Zika
San Diego biotech unit gets emergency FDA permission to test virus diagnostic kits
Big Sorrento Valley cash to be had from Zika
San Diego biotech unit gets emergency FDA permission to test virus diagnostic kits
Zika carrier Aedes aegypti during blood meal
The number of San Diego Zika virus infections continues its relentless growth, bringing the county to within one case of California Zika count leader Los Angeles, but at least one local big-money biotech outfit is looking to prosper from the worldwide breakout.
As of July 29, according to the latest report from the California Department of Public Health, San Diego has registered 23 infections, including one non-resident; L.A. has posted 24 cases.
Two weeks earlier, on July 15, Los Angeles was California's number-one Zika county by a wider margin, with 22 cases, while San Diego reported a total of 16. All of the 114 cases reported statewide so far in 2015 and 2016, including San Diego's, are travel-associated, according to state health officials.
San Diego's first Zika case was determined to be sexually transmitted this past February. "A San Diego man was visiting Colombia where he sustained some mosquito bites in January," according to a March 25 advisory from the county health department.
"Four days before his return to the county in early February, he had the onset of subjective fever, arthralgia, and maculopapular rash. Upon arrival in San Diego, he was still symptomatic with rash and arthralgia and he had unprotected sexual contact with a non-pregnant woman who had no travel outside the county."
The notice continued, "Seven days after initial sexual contact with the man, the woman developed fever to 101° F and a blanching, salmon to red colored, maculopapular rash on her trunk. The rash spread to her neck and extremities over the next two days and she developed arthralgia in her hands and feet."
The woman was subsequently determined to be infected with Zika, according to the federal Centers for Disease Control, and mosquito transmission was ruled out.
"Neither patient reported mosquito bites in San Diego and no Aedes species mosquitoes were detected in traps set by the San Diego County Vector Control Program around the residences of either patient," said the report.
Meanwhile, the onetime San Diego biotech start-up formerly known as Gen-Probe is looking to make hay with an experimental clinical test for the virus, which causes birth defects in babies of infected mothers.
Bought by Hologic, Inc. for $3.8 billion in cash back in 2012, the unit, still based in San Diego's Sorrento Valley on Genetic Center Drive, was issued an emergency-use authorization last month for its "Aptima® Zika Virus assay for the qualitative detection of RNA from Zika virus in human serum and plasma specimens," according to a June 17 letter to the firm from federal Food and Drug Administration commissioner of food and drugs Robert M. Califf.
"There is no adequate, approved, and available alternative to the emergency use of the Aptima® Zika Virus assay for detecting Zika virus and diagnosing Zika virus infection," according to the letter, which adds, "Hologic, Inc. will report to FDA any suspected occurrence of false positive and false negative results and significant deviations from the established performance characteristics of the test of which Hologic, Inc. becomes aware."
Adds the document, The known and potential benefits of the Aptima® Zika Virus assay for detecting Zika virus and diagnosing Zika virus infection outweigh the known and potential risks of such product.”
Four South Florida Zika cases found last week to be due to mosquito bites have ratcheted up the political pressure in Washington to provide more federal cash to combat the virus, ultimately translating to a potential windfall for Hologic.
But the news in San Diego is not all good for the company. In February of this year, Karmen Smiley, a former Genprobe accountant, sued Hologic in California superior court here, alleging she was harassed and let go after calling attention to illegal accounting practices by the firm last year, according to MassDevice.
“During her entire time working for Gen-Probe, and for the first few years working for Hologic, Ms. Smiley was never disciplined. In fact, she received numerous performance awards during her tenure. As recently as 2014, Ms. Smiley received a performance review stating she consistently meets and occasionally exceeds expectations,” the complaint said.
Hologic has denied the allegations, and the case has been moved to federal court, where it remains under litigation.
Comments